UPC NASDAQ
Universe Pharmaceuticals Inc.
1W: -5.3%
1M: -5.7%
3M: -25.0%
YTD: +8.2%
1Y: +2.3%
3Y: -99.2%
5Y: -100.0%
$4.50
+0.19 (+4.41%)
Weekly Expected Move ±12.3%
$3
$4
$4
$5
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$69M
+2.0% ▲
5Y CAGR: +19.2%
Total Liabilities
$13M
-41.3% ▼
5Y CAGR: +10.5%
Shareholders Equity
$56M
+23.4% ▲
5Y CAGR: +22.0%
Cash & Investments
$34M
+13.9% ▲
5Y CAGR: +27.3%
Total Debt
$9M
+15.8% ▲
5Y CAGR: +28.5%
Net Debt
-$24M
-13.2% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $8M | $6M | $5M | $29M | $34M |
| Short-Term Investments | $14M | $13M | $13M | $0 | $0 |
| Cash & ST Investments | $22M | $19M | $19M | $29M | $34M |
| Net Receivables | $16M | $15M | $11M | $18M | $13M |
| Inventory | $2M | $2M | $3M | $2M | $2M |
| Other Current Assets | $174K | $2M | $626K | $852K | $40K |
| Total Current Assets | $50M | $42M | $37M | $52M | $54M |
| Property, Plant & Equip. | $15M | $14M | $15M | $15M | $15M |
| Goodwill & Intangibles | $178K | $157K | $149K | $263K | $297K |
| Long-Term Investments | $745K | $703K | $685K | $712K | $702K |
| Other Non-Current Assets | $2M | $2M | $0 | $0 | $0 |
| Total Non-Current Assets | $20M | $18M | $16M | $16M | $16M |
| Total Assets | $70M | $60M | $53M | $68M | $69M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $3M | $5M | $5M | $2M |
| Short-Term Debt | $4M | $4M | $5M | $6M | $9M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $41K |
| Other Current Liabilities | $0 | $3M | $0 | $0 | $0 |
| Total Current Liabilities | $11M | $13M | $14M | $20M | $13M |
| Long-Term Debt | $0 | $0 | $0 | $2M | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $0 | $7M | $0 | $2M | $0 |
| Total Liabilities | $11M | $13M | $14M | $22M | $13M |
| — Equity — | |||||
| Common Stock | $68K | $68K | $68K | $482K | $6M |
| Retained Earnings | $25M | $16M | $10M | -$10M | -$14M |
| Accumulated OCI | $5M | $773K | $26K | $1M | $626K |
| Total Stockholders Equity | $59M | $46M | $40M | $46M | $56M |
| Total Liabilities & Equity | $70M | $60M | $53M | $68M | $69M |
| — Key Metrics — | |||||
| Total Debt | $4M | $4M | $5M | $8M | $9M |
| Net Debt | -$4M | -$2M | $197K | -$22M | -$24M |
| Total Investments | $14M | $14M | $14M | $712K | $702K |